Procactive, now also with registration for pigs of all weights! [Spain]
At Laboratorios Syva we are committed to the responsible use of antibiotics. Procactive 300 mg/ml Suspension for injection is part of Betaline, our range of beta-lactam antibiotics that provides solutions to the main bacterial diseases in production animals through individualised treatments.
Procactive 300 mg/ml Suspension for injection is indicated for the treatment of systemic infections in cattle, sheep and porcine caused by or associated with bacteria sensitive to benzylpenicillin.
In swine, it is now also registered for pigs under 25kg, it can be used on pigs of any weight. We recall that it is the only benzylpenicillin procaine 300 mg/ml registered for use in dairy sheep in Spain.
Benefits of Procactive:
1.Grupo D, tratamiento de primera elección[1].
2.Tiempos de espera muy cortos y adaptados a la duración del tratamiento:
Meat:
- 6 days for treatments with a duration of 3-5 days.
- 8 days for treatments with a duration of 6-7 days.
3. Amplitud de indicaciones
[1] Group D according to the antibiotic categorisation of the National Antibiotic Resistance Plan.
Learn more about Procactive and the Betaline range!
More about Procative
Consult our beta-lactams guide [Spanish]
You may also be interested in
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.
Media tool kit
We provide users, particularly journalists and the press, with a series of graphic documents, photographs and videos. We offer the free use of these documents under certain conditions
Journalist and Press Contact
Are you a journalist, part of the press or the media? Do you want to get information on our activities, validate your sources in a professional manner, obtain validated photographic material or request an interview?
Next Events
